{
    "clinical_study": {
        "@rank": "63697", 
        "arm_group": [
            {
                "arm_group_label": "2000 IU Vitamin D3- Cholecalciferol", 
                "arm_group_type": "Active Comparator", 
                "description": "Take 2000 IU crystalline vitamin D3 once/day for 12 weeks."
            }, 
            {
                "arm_group_label": "2000 IU Vitamin D2- Ergocalciferol", 
                "arm_group_type": "Active Comparator", 
                "description": "Take 2000 IU crystalline vitamin D2 supplement once/day for 12 weeks."
            }, 
            {
                "arm_group_label": "2000 IU  Mushroom Vitamin D2", 
                "arm_group_type": "Experimental", 
                "description": "Take 2000 IU vitamin D2 in a mushroom supplement once/day for 12 weeks"
            }, 
            {
                "arm_group_label": "Mushroom Extract", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Capsules with mushroom extract and no vitamin D. The intervention is mushroom extract."
            }
        ], 
        "brief_summary": {
            "textblock": "This study will evaluate how much vitamin D is present in a mushroom supplement. This\n      supplement contains an extract from mushrooms that have been exposed to sunlight. The\n      mushroom supplement will be compared to non-commercially available vitamin D supplements\n      produced in a Goo Manufacturing Practices (GMP)-licensed facility."
        }, 
        "brief_title": "Evaluating Vitamin D Content in Mushrooms", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Vitamin D Deficiency", 
        "condition_browse": {
            "mesh_term": "Vitamin D Deficiency"
        }, 
        "detailed_description": {
            "textblock": "Mushrooms have the capability to produce vitamin D in a similar way to human skin. When\n      exposed to ultraviolet light, mushrooms will convert a precursor to vitamin D. This reaction\n      produces large amounts of vitamin D. This study is comparing a natural source of vitamin D\n      to a synthetic source of vitamin D and will help determine if mushrooms are a novel source\n      for this essential nutrient."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All healthy adults, male and female, age 18-64 years\n\n        Exclusion Criteria:\n\n          -  Currently taking, or having taken less than one month prior to start of study, a\n             prescription of 50,000 IU of vitamin D2 or 2000 IU vitamin D2 or vitamin D3\n\n          -  Allergy to mushrooms\n\n          -  History of elevated calcium (>10.4 mg%)\n\n          -  Patients with a current or recent history of severe, progressive, and/or uncontrolled\n             renal, hepatic, hematological, endocrine, pulmonary, cardiac, neurological, or\n             cerebral disease.\n\n          -  Supplementation with over the counter formulations of vitamin D2 or vitamin D3\n\n          -  Subjects with a history of an adverse reaction to orally administered vitamin D.\n\n          -  Subjects who are taking oral Dilantin or glucocorticoids.\n\n          -  Exposure to a tanning bed or tanning on a beach for more than eight hours with no\n             sunscreen within 2 weeks prior to start of study.\n\n          -  History of intestinal malabsorption (i.e. cystic fibrosis, fat malabsorption\n             syndrome, Crohn's Disease, gastric bypass surgery).\n\n          -  Subjects with any other condition which in the Investigator's judgment would make the\n             patient unsuitable for inclusion in the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "64 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 2, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01815437", 
            "org_study_id": "MU100"
        }, 
        "intervention": [
            {
                "arm_group_label": "2000 IU  Mushroom Vitamin D2", 
                "description": "2000 IU vitamin D2 in a mushroom extract, once/day for 12 weeks", 
                "intervention_name": "Mushroom Vitamin D2", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Ergocalciferol"
            }, 
            {
                "arm_group_label": "2000 IU Vitamin D3- Cholecalciferol", 
                "description": "2000 IU crystalline cholecalciferol once/day for 12 weeks", 
                "intervention_name": "Cholecalciferol", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Cholecalciferol"
            }, 
            {
                "arm_group_label": "2000 IU Vitamin D2- Ergocalciferol", 
                "description": "2000 IU vitamin D2, ergocalciferol once/day for 12 weeks", 
                "intervention_name": "Vitamin D2 - Ergocalciferol", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Ercocalciferol"
            }, 
            {
                "arm_group_label": "Mushroom Extract", 
                "description": "Same quantity of mushroom extract in a capsule", 
                "intervention_name": "Mushroom Extract", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cholecalciferol", 
                "Ergocalciferols", 
                "Vitamin D", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 19, 2013", 
        "location": {
            "contact": {
                "email": "mfholick@bu.edu", 
                "last_name": "Michael F Holick, PhD MD"
            }, 
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02118"
                }, 
                "name": "Boston Medical Center"
            }, 
            "investigator": [
                {
                    "last_name": "Michael F Holick, PhD, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Jaimee M Bogusz, BS", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Garyfallia Pagonis, BFA", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Evaluation of Vitamin D in a Mushroom Supplement", 
        "overall_official": {
            "affiliation": "Boston Medical Center", 
            "last_name": "Michael F Holick, PhD, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary outcome of this study is to examine changes in total 25(OH)D levels after ingestion of a vitamin D2 mushroom supplement manufactured by Monterey Mushrooms, Inc. compared to crystalline vitamin D2 from Nature's Life or vitamin D3 manufactured by Whole Health, Inc.", 
            "measure": "Changes in total 25(OH)D in mushroom supplement or crystalline supplement", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "reference": [
            {
                "PMID": "17634462", 
                "citation": "Holick MF. Vitamin D deficiency. N Engl J Med. 2007 Jul 19;357(3):266-81. Review. No abstract available."
            }, 
            {
                "PMID": "18524740", 
                "citation": "Rovner AJ, O'Brien KO. Hypovitaminosis D among healthy children in the United States: a review of the current evidence. Arch Pediatr Adolesc Med. 2008 Jun;162(6):513-9. doi: 10.1001/archpedi.162.6.513. Review."
            }, 
            {
                "PMID": "19661054", 
                "citation": "Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML. Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics. 2009 Sep;124(3):e362-70. doi: 10.1542/peds.2009-0051. Epub 2009 Aug 3."
            }, 
            {
                "PMID": "19064511", 
                "citation": "Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr. 2008 Dec;88(6):1519-27. doi: 10.3945/ajcn.2008.26182."
            }, 
            {
                "PMID": "16497887", 
                "citation": "Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Z\u00fcgel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006 Mar 24;311(5768):1770-3. Epub 2006 Feb 23."
            }, 
            {
                "PMID": "19237723", 
                "citation": "Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009 Feb 23;169(4):384-90."
            }, 
            {
                "PMID": "18089691", 
                "citation": "Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, Reitz R, Salameh W, Ameri A, Tannenbaum AD. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab. 2008 Mar;93(3):677-81. Epub 2007 Dec 18."
            }, 
            {
                "PMID": "21118827", 
                "citation": "Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011 Jan;96(1):53-8. doi: 10.1210/jc.2010-2704. Epub 2010 Nov 29."
            }, 
            {
                "PMID": "19858440", 
                "citation": "Pietras SM, Obayan BK, Cai MH, Holick MF. Vitamin D2 treatment for vitamin D deficiency and insufficiency for up to 6 years. Arch Intern Med. 2009 Oct 26;169(19):1806-8. doi: 10.1001/archinternmed.2009.361."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01815437"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The secondary outcome is to look at changes in gene expression, specifically if ingestion of 2000 IU vitamin D2 in a dried mushroom extract and the same quantity of mushroom extract once/day for three months has any added benefits or differences compared to taking crystalline vitamin D2 or vitamin D3.", 
            "measure": "Changes in gene expression due to mushroom supplement or crystalline supplement", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "source": "Boston Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Boston Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}